Literature DB >> 7984355

Physical dependence produced by central morphine infusions: an anatomical mapping study.

M A Bozarth1.   

Abstract

Morphine sulfate (1.5 nmoles/h) was chronically infused into various brain regions in rats. After 72 h of continuous infusions, an intraperitoneal injection of naloxone hydrochloride (5 mg/kg) was given to determine if physical dependence had developed. Various withdrawal signs were present following the naloxone challenge in rats chronically infused with morphine into the periventricular gray region. These withdrawal signs included escape behavior, wet-dog shakes, and teeth chattering. Several other brain regions (e.g., amygdala, caudate nucleus, lateral hypothalamus, nucleus accumbens, thalamus) were also tested, but morphine infusions into these areas produced only slight physical dependence. The magnitude of physical dependence produced by morphine infusions into the rostral aspect of the periventricular gray was comparable to that seen following repeated systemic morphine injections, while the physical dependence produced by caudal infusions into the vicinity of the locus coeruleus was considerably less. These data confirm the importance of the periventricular gray region in the development of physical dependence on morphine and reveal that a drug action in the more rostral aspect of this brain region produces the strongest signs of physical dependence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7984355     DOI: 10.1016/0149-7634(94)90050-7

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  11 in total

1.  Local opioid withdrawal in rat single periaqueductal gray neurons in vitro.

Authors:  B Chieng; M D Christie
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

Review 2.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

3.  MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in rats.

Authors:  T Iida; H Yi; S Liu; D Ikegami; W Zheng; Q Liu; K Takahashi; Y Kashiwagi; W F Goins; J C Glorioso; S Hao
Journal:  Gene Ther       Date:  2017-04-03       Impact factor: 5.250

4.  IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats.

Authors:  H Yi; T Iida; S Liu; D Ikegami; Q Liu; A Iida; D A Lubarsky; S Hao
Journal:  Gene Ther       Date:  2017-03-16       Impact factor: 5.250

5.  The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats.

Authors:  Shuanglin Hao; Shue Liu; Xuexing Zheng; Wenwen Zheng; Handong Ouyang; Marina Mata; David J Fink
Journal:  Neuropsychopharmacology       Date:  2010-11-10       Impact factor: 7.853

6.  Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addiction.

Authors:  T A Ignatowski; R Aalinkeel; J L Reynolds; B B Nair; D E Sykes; C P K Gleason; W C Law; M J Mammen; P N Prasad; S A Schwartz; Supriya D Mahajan
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-22       Impact factor: 4.147

Review 7.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

8.  Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.

Authors:  F Noble; B M Cox
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway.

Authors:  S L Ingram; C W Vaughan; E E Bagley; M Connor; M J Christie
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

10.  Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).

Authors:  Mark R Hutchinson; Susannah S Lewis; Benjamen D Coats; David A Skyba; Nicole Y Crysdale; Debra L Berkelhammer; Anita Brzeski; Alexis Northcutt; Christine M Vietz; Charles M Judd; Steven F Maier; Linda R Watkins; Kirk W Johnson
Journal:  Brain Behav Immun       Date:  2008-10-04       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.